Related articles

• Potential clinical application of microRNAs in bladder cancer
  2024, 38(4): 289-306. DOI: 10.7555/JBR.37.20230245
• LncRNA LINC01503 promotes angiogenesis in colorectal cancer by regulating VEGFA expression via miR-342-3p and HSP60 binding
  DOI: 10.7555/JBR.38.20240190
• Identification of four novel prognosis biomarkers and potential therapeutic drugs for human colorectal cancer by bioinformatics analysis
  2021, 35(1): 21-35. DOI: 10.7555/JBR.34.20200021
• Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer
  2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
• Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy
  2016, 30(6): 452-465. DOI: 10.7555/JBR.30.20150111
• The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers
  2016, 30(6): 441-451. DOI: 10.7555/JBR.30.20150109
• Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer
  2013, 27(4): 283-290. DOI: 10.7555/JBR.27.20130069
• Baicalin modulates microRNA expression in UVB irradiated mouse skin
  2012, 26(2): 125-134. DOI: 10.1016/S1674-8301(12)60022-0
• Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancer
  2010, 24(3): 187-197.
• The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-π as clinico-histopathological markers for colorectal cancer
  2010, 24(1): 51-57.